Ten Year Symposium - Tolerance In ANCA-Associated Vasculitis

Ulrich Specks, MD is a Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic.  Dr. Specks is involved in clinical research studies aimed at the identification of novel, more efficacious and safer treatment modalities for patients with Wegener’s granulomatosis, ANCA-associated vasculitis and pulmonary fibrosis. He is the co-principal investigator (together with Dr. John H. Stone, Massachusetts General Hospital) for the multicenter trial "Rituximab Therapy for the Induction of Remission and Tolerance in ANCA-associated Vasculitis (RAVE)" sponsored by the ITN.